Back

An updated meta-analysis: The effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the mortality of hypertensive patients with confirmed COVID-19 infection

2 December 2022 (10:30 - 10:36)
Organised by:
Congress Presentation Part of: Special Populations Treatment ESC Professional Premium Access ESC Asia 2022 with APSC & AFC

About the speaker

Photo
Doctor Maria Kristina Manalili Pamplona

Cardinal Santos Medical Center, San Juan (Philippines)

3 More presentations in this session

Presentation thumbnail
HbA1c variability is associated with adverse outcomes in heart failure patients with and without diabetes
Doctor Q. Ren (Hong Kong, HK)
Abstract
Presentation thumbnail
Prevalence, mortality, and disability-adjusted-life-years resulting from aortic aneurysm burden and its association with the socio-demographic index in Asia, 1990-2019: Results from the GBD 2019
Professor L. Gobolos (Abu Dhabi, AE)
Slides
Presentation thumbnail
Key comorbidities and laboratory findings: insights from first prospective, observational and Multi-Center Malaysia Heart Failure (MYHF) registry
Professor W. Wan Ahmad (Kuala Lumpur, MY)
Abstract Slides

Access the full session

Session thumbnail
Special Populations

The Event

Event poster

ESC Asia 2022 with APSC & AFC

2 December 2022 10:30 CET
You may be interested in
thumbnail
Congress Presentation
What is new in hypertension: highlights from the 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension
thumbnail
Congress Presentation
Add-on treatment with zilebesiran for inadequately controlled hypertension: KARDIA-2 RCT
thumbnail
Congress Presentation
When to start drug treatment and new blood pressure treatment targets

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources